Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease

Alexandra Gauthier-Bastien1, Roth-Visal Ung, Richard Larivière

  • 1Nephrology & Hypertension Research Unit, CHU de Québec Research Centre, L'Hôtel-Dieu de Québec Hospital and Department of Medicine, Université Laval , Quebec , Canada.

Insights

Chronic kidney disease (CKD) in rats leads to arterial stiffness. Smooth muscle cell changes and blood vessel remodeling contribute to this stiffness and vascular calcification in CKD.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • Cardiovascular disease is a leading cause of mortality in chronic kidney disease (CKD) patients.
  • Arterial stiffness and vascular calcification are key non-traditional risk factors for cardiovascular disease in CKD.
  • The study investigates the role of smooth muscle cell differentiation and vascular remodeling in arterial stiffness within CKD.

Purpose of the Study:

  • To investigate the mechanisms linking smooth muscle cell differentiation to osteoblast-like cells.
  • To understand the role of vascular media remodeling and calcification in arterial stiffness in CKD.
  • To analyze the changes in cellular components of the blood vessel wall associated with increased arterial stiffness.

Main Methods:

  • CKD and vascular calcification induced in rats via subtotal nephrectomy, high calcium/phosphate diet, and vitamin D.
  • Hemodynamic parameters and pulse wave velocity (PWV) measured at weeks 3-6.
  • Vascular media calcification and remodeling assessed using von Kossa staining and immunofluorescence for osteocalcin, elastin, α-SMA, and collagen-1.

Main Results:

  • CKD rats showed significantly increased pulse pressure and PWV, with marked media calcification.
  • Osteocalcin expression increased, while α-smooth muscle actin (α-SMA) and elastin levels decreased in calcified areas.
  • Reduced α-SMA and elastin levels correlated inversely with PWV, indicating increased arterial stiffness.

Conclusions:

  • Smooth muscle cell differentiation into osteoblast-like cells contributes to arterial stiffness in CKD.
  • Vascular media remodeling, including elastic lamella disruption and collagen deposition, is associated with increased arterial stiffness.
  • These cellular and structural changes are key factors in the development of arterial stiffness in CKD with vascular calcification.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...